Table 3: Demographic and echocardiographic predictors of outcomes.
|
|
1-year mortality |
Post-op myocardial injury |
Hospital readmissions |
||||||
|
|
No.(%)/mean ± SD |
||||||||
|
Variable |
Died (n = 6) |
Survived (n = 36) |
p-value |
MI (n = 12) |
No MI (n = 30) |
p-value |
Readmitted (n = 21) |
Event free (n = 21) |
p-value |
|
Male gender |
5 (83.3) |
21 (58.3) |
0.380 |
8 (66.7) |
18 (60.0) |
0.740 |
12 (57.1) |
14 (66.7) |
0.525 |
|
Age (yr) |
79.7 ± 10.9 |
71.1 ± 12.9 |
0.131 |
75.4 ± 12.6 |
71.0 ± 12.9 |
0.325 |
72.4 ± 11.6 |
72.2 ± 14.3 |
0.962 |
|
Creatinine (µmol/L) |
84.7 ± 72.4 |
164.9 ± 196.6 |
0.333 |
157.4 ± 155.6 |
151.8 ± 198.8 |
0.931 |
156.2 ± 232.4 |
150.6 ± 128.8 |
0.923 |
|
Diabetes |
3 (50.0) |
20 (55.6) |
1.000 |
6 (50.0) |
17 (56.7) |
0.695 |
12 (57.1) |
11 (52.4) |
0.757 |
|
Hyperlipidemia |
5 (83.3) |
25 (69.4) |
0.655 |
8 (66.7) |
22 (73.3) |
0.715 |
15 (71.4) |
15 (71.4) |
1.000 |
|
Hypertension |
5 (83.3) |
29 (80.6) |
1.000 |
11 (91.7) |
23 (76.7) |
0.402 |
16 (76.2) |
18 (85.7) |
0.697 |
|
Atrial fibrillation |
1 (16.7) |
5 (13.9) |
1.000 |
3 (25.0) |
3 (10.0) |
0.329 |
4 (19.0) |
2 (9.5) |
0.663 |
|
CCF |
0 (0.0) |
5 (13.9) |
1.000 |
3 (25.0) |
2 (6.7) |
0.131 |
2 (9.5) |
3 (14.3) |
1.000 |
|
IHD |
2 (33.3) |
10 (27.8) |
1.000 |
7 (58.3) |
5 (16.7) |
0.019* |
8 (38.1) |
4 (19.0) |
0.172 |
|
CVA/TIA |
1 (16.7) |
6 (16.7) |
1.000 |
3 (25.0) |
4 (13.3) |
0.387 |
2 (9.5) |
5 (23.8) |
0.410 |
|
Active cancer |
4 (66.7) |
7 (19.4) |
0.032* |
2 (16.7) |
9 (30.0) |
0.464 |
8 (38.1) |
3 (14.3) |
0.079 |
|
GLS (%) |
-18.95 ± 1.57 |
-23.75 ± 3.21 |
0.001* |
-23.45 ± 2.79 |
-22.91 ± 3.72 |
0.653 |
-23.37 ± 2.92 |
-22.76 ± 3.97 |
0.571 |
|
E/A ratio |
0.74 ± 0.26 |
0.93 ± 0.28 |
0.178 |
0.84 ± 0.27 |
0.92 ± 0.29 |
0.480 |
0.94 ± 0.26 |
0.87 ± 0.31 |
0.467 |
|
E/e’ |
9.6 ± 2.6 |
13.2 ± 6.7 |
0.213 |
12.4 ± 6.8 |
12.7 ± 6.2 |
0.924 |
13.9 ± 6.6 |
11.1 ± 5.7 |
0.174 |
|
LA size indexed (ml/m2) |
35.9 ± 11.4 |
31.2 ± 9.3 |
0.419 |
29.9 ± 8.8 |
32.3 ± 9.8 |
0.523 |
32.3 ± 10.5 |
30.8 ± 8.3 |
0.656 |
|
TR Vmax (m/s) |
2.30 ± 0.54 |
2.46 ± 0.63 |
0.630 |
2.58 ± 0.82 |
2.39 ± 0.50 |
0.382 |
2.40 ± 0.69 |
2.50 ± 0.51 |
0.641 |
*p < 0.05 is considered statistically significant.
CCF: Congestive Cardiac Failure; CVA: Cerebrovascular Accident; IHD: Ischaemic Heart Disease; LA: Left Atrium; MI: Myocardial Injury; TIA: Transient Ischaemic Attack; TR Vmax: Maximal Tricuspid Regurgitation Velocity